The Novel Platform of Discovery and Engineering TCR Mimic Antibodies to Enhance Therapeutic Index of Efficacy and Safety

Time: 11:30 am
day: Day Two


• Examining methods to engineer TCR mimic antibodies to magnify specificity for target antigens
• Reviewing the pros and cons of affinity enhanced TCR mimic antibodies to safeguard patient safety
• Escalating affinity to the target peptide as well as the MHC to optimize efficacy